Abstract
Tissue repair post injury is a multi-step wound healing process and consists of inflammatory, proliferative, and remodeling phases, which are coordinated by interplays between many resident and infiltrating cells as well as growth factors and extracellular matrix proteins. Macrophages are major cell populations regulating inflammation by initiation, propagation, and resolution. Activated macrophages that are differentially polarized, either classically or alternatively, are also called pro-inflammatory M1 and anti-inflammatory M2, respectively. These macrophages participate in the whole process of tissue repair. The contribution of multi-potent mesenchymal stem cells (MSCs) in tissue repair, either endogenous or therapeutically injected, has been addressed in a variety of degenerative and inflammatory disease models. Initially, the role of MSCs in the tissue repair process was restricted to the replacement of dysfunctional cells by either mesenchymal differentiation or transdifferentiation into other lineages. However, growing evidence has clearly defined MSCs as beneficial cells in tissue repair via immunomodulatory functions. In this review, we intend to summarize recent important observations in two essential cell components, MSCs and macrophages, in the context of tissue repair. Individual roles of MSCs and macrophages as well as the crosstalk between these two types of cells are discussed. The roles of both MSC-educated macrophages and macrophage-associated MSCs during tissue repair are also discussed.
Similar content being viewed by others
References
JA Ankrum, JF Ong, JM Karp, Mesenchymal stem cells: immune evasive, not immune privileged, Nat Biotechnol, 32, 252 (2014).
M Dominici, K Le Blanc, I Mueller, et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315 (2006).
K English, Mechanisms of mesenchymal stromal cell immunomodulation, Immunol Cell Biol, 91, 19 (2013).
S Ma, N Xie, W Li, et al., Immunobiology of mesenchymal stem cells, Cell Death Differ, 21, 216 (2014).
ME Bernardo, WE Fibbe, Mesenchymal stromal cells: sensors and switchers of inflammation, Cell Stem Cell, 13, 392 (2013).
Y Shi, J Su, AI Roberts, et al., How mesenchymal stem cells interact with tissue immune responses, Trends Immunol, 33, 136 (2012).
K Le Blanc, D Mougiakakos, Multipotent mesenchymal stromal cells and the innate immune system, Nat Rev Immunol, 12, 383 (2012).
S Maxson, EA Lopez, D Yoo, et al., Concise review: role of mesenchymal stem cells in wound repair, Stem Cells Transl Med, 1, 142 (2012).
H Choi, RH Lee, N Bazhanov, et al., Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NFkappaB signaling in resident macrophages, Blood, 118, 330 (2011).
AJ Cutler, V Limbani, J Girdlestone, et al., Umbilical cordderived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation, J Immunol, 185, 6617 (2010).
K English, FP Barry, BP Mahon, Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation, Immunol Lett, 115, 50 (2008).
K Nemeth, A Leelahavanichkul, PS Yuen, et al., Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat Med, 15, 42 (2009).
J Kim, P Hematti, Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages, Exp Hematol, 37, 1445 (2009).
J Maggini, G Mirkin, I Bognanni, et al., Mouse bone marrowderived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile, PLoS One, 5, e9252 (2010).
DJ Prockop, Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation, Stem Cells, 31, 2042 (2013).
R Carrero, I Cerrada, E Lledo, et al., IL1beta induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-kappaB, Stem Cell Rev, 8, 905 (2012).
RS Waterman, SL Tomchuck, SL Henkle, et al., A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype, PLoS One, 5, e10088 (2010).
DI Cho, MR Kim, HY Jeong, et al., Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages, Exp Mol Med, 46, e70 (2014).
SM Melief, E Schrama, MH Brugman, et al., Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward antiinflammatory macrophages, Stem Cells, 31, 1980 (2013).
C Shi, T Jia, S Mendez-Ferrer, et al., Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands, Immunity, 34, 590 (2011).
SM Melief, SB Geutskens, WE Fibbe, et al., Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6, Haematologica, 98, 888 (2013).
A Mantovani, SK Biswas, MR Galdiero, et al., Macrophage plasticity and polarization in tissue repair and remodelling, J Pathol, 229, 176 (2013).
A Sica, A Mantovani, Macrophage plasticity and polarization: in vivo veritas, J Clin Invest, 122, 787 (2012).
SD Ricardo, H van Goor, AA Eddy, Macrophage diversity in renal injury and repair, J Clin Invest, 118, 3522 (2008).
A Mantovani, A Sica, S Sozzani, et al., The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol, 25, 677 (2004).
L Arnold, A Henry, F Poron, et al., Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis, J Exp Med, 204, 1057 (2007).
C Troidl, H Mollmann, H Nef, et al., Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction, J Cell Mol Med, 13, 3485 (2009).
B Mahdavian Delavary, WM van der Veer, M van Egmond, et al., Macrophages in skin injury and repair, Immunobiology, 216, 753 (2011).
MH Jiang, E Chung, GF Chi, et al., Substance P induces M2- type macrophages after spinal cord injury, Neuroreport, 23, 786 (2012).
T Lucas, A Waisman, R Ranjan, et al., Differential roles of macrophages in diverse phases of skin repair, J Immunol, 184, 3964 (2010).
H Nakajima, K Uchida, AR Guerrero, et al., Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury, J Neurotrauma, 29, 1614 (2012).
RH Lee, AA Pulin, MJ Seo, et al., Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6, Cell Stem Cell, 5, 54 (2009).
M Sasaki, R Abe, Y Fujita, et al., Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type, J Immunol, 180, 2581 (2008).
Y Wu, L Chen, PG Scott, et al., Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis, Stem Cells, 25, 2648 (2007).
QZ Zhang, WR Su, SH Shi, et al., Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing, Stem Cells, 28, 1856 (2010).
E Eggenhofer, MJ Hoogduijn, Mesenchymal stem cell-educated macrophages, Transplant Res, 1, 12 (2012).
D Giunti, B Parodi, C Usai, et al., Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1, Stem Cells, 30, 2044 (2012).
H Ohtaki, JH Ylostalo, JE Foraker, et al., Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses, Proc Natl Acad Sci U S A, 105, 14638 (2008).
DO Freytes, JW Kang, I Marcos-Campos, et al., Macrophages modulate the viability and growth of human mesenchymal stem cells, J Cell Biochem, 114, 220 (2013).
K Anton, D Banerjee, J Glod, Macrophage-associated mesenchymal stem cells assume an activated, migratory, proinflammatory phenotype with increased IL-6 and CXCL10 secretion, PLoS One, 7, e35036 (2012).
JJ Koning, G Kooij, HE de Vries, et al., Mesenchymal stem cells are mobilized from the bone marrow during inflammation, Front Immunol, 4, 49 (2013).
SP Herbert, DY Stainier, Molecular control of endothelial cell behaviour during blood vessel morphogenesis, Nat Rev Mol Cell Biol, 12, 551 (2011).
TS Stappenbeck, H Miyoshi, The role of stromal stem cells in tissue regeneration and wound repair, Science, 324, 1666 (2009).
Y Okuno, A Nakamura-Ishizu, K Kishi, et al., Bone marrowderived cells serve as proangiogenic macrophages but not endothelial cells in wound healing, Blood, 117, 5264 (2011).
H He, J Xu, CM Warren, et al., Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages, Blood, 120, 3152 (2012).
RJ Medina, CL O’Neill, TM O’Doherty, et al., Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8, Mol Med, 17, 1045 (2011).
MJ Lee, MY Kim, SC Heo, et al., Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F(2)alpha-mediated paracrine mechanism, Arterioscler Thromb Vasc Biol, 32, 2733 (2012).
KL Spiller, RR Anfang, KJ Spiller, et al., The role of macrophage phenotype in vascularization of tissue engineering scaffolds, Biomaterials, 35, 4477 (2014).
HS Hong, J Lee, E Lee, et al., A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells, Nat Med, 15, 425 (2009).
HS Hong, YD Kim, KJ Yoon, et al., A new paradigm for stem cell therapy: substance-P as a stem cell-stimulating agent, Arch Pharm Res, 34, 2003 (2011).
MH Jiang, JE Lim, GF Chi, et al., Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury, Neuroreport, 24, 846 (2013).
W Ahn, HS Hong, M Zhang, et al., Induction of mesenchymal to epithelial transition of circulating mesenchymal stem cells by conditioned medium of injured cornea, Tissue Eng Regen Med, 10, 86 (2013).
E Chung, W Ahn, Y Son, CXCL5 is abundant in the wound fluid at the late phase of wound healing, possibly promoting migration of mesenchymal stem cells and vascular tube formation, Tissue Eng Regen Med, 11, 1 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chung, E., Son, Y. Crosstalk between mesenchymal stem cells and macrophages in tissue repair. Tissue Eng Regen Med 11, 431–438 (2014). https://doi.org/10.1007/s13770-014-0072-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-014-0072-1